Epkinly 4 mg/0.8 mL injection Images
Generic Name: epcoritamab
This medication has been identified as Epkinly 4 mg/0.8 mL injection and is used for Diffuse Large B-Cell Lymphoma, B-Cell Lymphoma, and Follicular Lymphoma. It belongs to the drug class bispecific T-cell engagers (BiTE) and is not a controlled substance.
Images of medication
Epkinly
- Generic Name
- epcoritamab
- Strength
- 4 mg/0.8 mL injection
- Availability
- Prescription only
- Drug Class
- Bispecific T-cell engagers (BiTE)
- CSA Schedule
- Not a controlled drug
- Labeler / Supplier
- AbbVie Inc.
- National Drug Code (NDC)
- 82705-0002
See also:
More about Epkinly (epcoritamab)
- Check interactions
- Compare alternatives
- Pricing & coupons
- Drug images
- Side effects
- Dosage information
- During pregnancy
- FDA approval history
- Drug class: bispecific T-cell engagers (BiTE)
- Breastfeeding
- En español
Patient resources
Professional resources
Related treatment guides
Further information
Always consult your healthcare provider to ensure the information displayed on this page applies to your personal circumstances.